Results 181 to 190 of about 57,707 (307)

Differences and Commonalities of Electrical Stimulation Paradigms After Central Paralysis and Amputation

open access: yesArtificial Organs, EarlyView.
Invasive and non‐invasive functional electrical stimulation (FES) is a well‐established method to partially restore function after paralysis and deliver sensory feedback after amputation. This work summarizes the current state‐of‐the‐art of FES for restoring function, supporting rehabilitation therapy, and assistive devices.
Thomas Stieglitz   +3 more
wiley   +1 more source

Fully Implantable Wireless Cardiac Pacing and Sensing System Integrated with Hydrogel Electrodes. [PDF]

open access: yesAdv Sci (Weinh)
Chang Z   +11 more
europepmc   +1 more source

Sustainability in Healthcare: The Role of Digital Technologies for Improving Patient Engagement

open access: yesBusiness Ethics, the Environment &Responsibility, EarlyView.
ABSTRACT Sustainability in healthcare is getting considerable research attention as systems worldwide tend to balance environmental, social, and economic factors. In this context, digital technologies have demonstrated significant potential to enhance engagement among different consumer groups across various industries.
Francesco Schiavone   +4 more
wiley   +1 more source

Transcriptome Sequencing Reveals the Molecular Mechanism of Heat Stroke-Induced Myocardial Injury

open access: yesJournal of Inflammation Research
Jie Xiang,1,2,* Shijie Shao,1,2,* Jie Huang,3 Na Yang,1,2 Fei Guo,4 Baopeng Tang,1,2 Ling Zhang1,2 1Xinjiang Key Laboratory of Cardiac Electrophysiology and Remodeling, Clinical Medical Research Institute, The First Affiliated Hospital of
Xiang J   +6 more
doaj  

The Practice of Deep Sedation in Electrophysiology and Cardiac Pacing Laboratories: Results of an Italian Survey Promoted by the AIAC (Italian Association of Arrhythmology and Cardiac Pacing). [PDF]

open access: yesJ Clin Med, 2021
Palmisano P   +15 more
europepmc   +1 more source

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Mavacamten (MAVA) is a novel small molecule inhibitor of cardiac myosin, mitigating cardiomyocyte hypercontractility in patients with hypertrophic obstructive cardiomyopathy (HOCM). Despite its recent approval for clinical use, the transcriptional and functional impacts of MAVA remain not well understood.
Elisa Kiselev   +36 more
wiley   +1 more source

Home - About - Disclaimer - Privacy